PASG
Passage BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PASG Profile
Passage Bio, Inc.
A clinical-stage genetic medicines company that develops therapies for the treatment of rare monogenic central nervous system diseases
Biological Technology
07/26/2017
02/28/2020
NASDAQ Stock Exchange
60
12-31
Common stock
One Commerce Square
, 2005 Market Street
, 39th Floor
, Philadelphia
, PA 19103
--
Passage Bio, Inc., a Delaware-based company founded on July 26, 2017, is a genetic medicine company focused on the development of translational therapies for rare single-gene central nervous system diseases. Its vision is to become a leading genetic medicine company and actively change the lives of patients whose lives are threatened by these diseases.
